Market Closed -
Nyse
16:00:02 2024-04-26 EDT
|
5-day change
|
1st Jan Change
|
134.3
USD
|
-0.86%
|
|
+4.53%
|
-2.63%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
14,384
|
16,060
|
21,224
|
17,817
|
15,503
|
14,915
|
-
|
-
|
Enterprise Value (EV)
1 |
17,962
|
18,917
|
24,364
|
21,482
|
19,683
|
18,982
|
18,351
|
18,093
|
P/E ratio
|
17
x
|
11.4
x
|
11.1
x
|
19.6
x
|
18.4
x
|
17.2
x
|
15.8
x
|
14.2
x
|
Yield
|
1.99%
|
1.88%
|
1.53%
|
1.69%
|
-
|
2.15%
|
2.22%
|
2.26%
|
Capitalization / Revenue
|
1.86
x
|
1.7
x
|
1.97
x
|
1.8
x
|
1.68
x
|
1.58
x
|
1.53
x
|
1.48
x
|
EV / Revenue
|
2.32
x
|
2
x
|
2.26
x
|
2.17
x
|
2.13
x
|
2.01
x
|
1.88
x
|
1.8
x
|
EV / EBITDA
|
11.6
x
|
7.66
x
|
8.49
x
|
10.4
x
|
11
x
|
10.1
x
|
9.22
x
|
8.71
x
|
EV / FCF
|
21.3
x
|
11.9
x
|
13.3
x
|
16.3
x
|
22.8
x
|
21.2
x
|
16.8
x
|
14.6
x
|
FCF Yield
|
4.69%
|
8.39%
|
7.51%
|
6.12%
|
4.39%
|
4.72%
|
5.95%
|
6.86%
|
Price to Book
|
2.52
x
|
2.34
x
|
3.19
x
|
2.95
x
|
-
|
2.18
x
|
2.01
x
|
1.83
x
|
Nbr of stocks (in thousands)
|
134,697
|
134,766
|
122,675
|
113,887
|
112,435
|
111,092
|
-
|
-
|
Reference price
2 |
106.8
|
119.2
|
173.0
|
156.4
|
137.9
|
134.3
|
134.3
|
134.3
|
Announcement Date
|
20-01-30
|
21-02-04
|
22-02-03
|
23-02-02
|
24-02-01
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
7,726
|
9,437
|
10,788
|
9,883
|
9,252
|
9,448
|
9,750
|
10,072
|
EBITDA
1 |
1,549
|
2,468
|
2,870
|
2,059
|
1,788
|
1,885
|
1,990
|
2,078
|
EBIT
1 |
1,220
|
2,107
|
2,462
|
1,742
|
1,457
|
1,515
|
1,611
|
1,715
|
Operating Margin
|
15.79%
|
22.33%
|
22.82%
|
17.63%
|
15.75%
|
16.04%
|
16.52%
|
17.02%
|
Earnings before Tax (EBT)
1 |
1,076
|
1,884
|
2,599
|
1,235
|
1,130
|
1,206
|
1,296
|
1,411
|
Net income
1 |
858
|
1,431
|
1,995
|
946
|
854
|
894.3
|
960.5
|
1,048
|
Net margin
|
11.11%
|
15.16%
|
18.49%
|
9.57%
|
9.23%
|
9.47%
|
9.85%
|
10.41%
|
EPS
2 |
6.280
|
10.47
|
15.55
|
7.970
|
7.490
|
7.823
|
8.520
|
9.427
|
Free Cash Flow
1 |
843
|
1,587
|
1,830
|
1,314
|
864
|
895.4
|
1,091
|
1,241
|
FCF margin
|
10.91%
|
16.82%
|
16.96%
|
13.3%
|
9.34%
|
9.48%
|
11.19%
|
12.32%
|
FCF Conversion (EBITDA)
|
54.42%
|
64.3%
|
63.76%
|
63.82%
|
48.32%
|
47.51%
|
54.83%
|
59.7%
|
FCF Conversion (Net income)
|
98.25%
|
110.9%
|
91.73%
|
138.9%
|
101.17%
|
100.12%
|
113.62%
|
118.39%
|
Dividend per Share
2 |
2.120
|
2.240
|
2.640
|
2.640
|
-
|
2.888
|
2.977
|
3.029
|
Announcement Date
|
20-01-30
|
21-02-04
|
22-02-03
|
23-02-02
|
24-02-01
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
2,744
|
2,611
|
2,453
|
2,486
|
2,333
|
2,331
|
2,338
|
2,295
|
2,288
|
2,366
|
2,395
|
2,365
|
2,330
|
2,426
|
2,479
|
EBITDA
1 |
659
|
660
|
515
|
504
|
407
|
431
|
473
|
464
|
420
|
436
|
487
|
484.3
|
462.6
|
459.6
|
504.6
|
EBIT
1 |
553
|
554
|
435
|
423
|
330
|
350
|
389
|
380
|
338
|
349
|
404.6
|
398.2
|
365.3
|
373.3
|
429.8
|
Operating Margin
|
20.15%
|
21.22%
|
17.73%
|
17.02%
|
14.14%
|
15.02%
|
16.64%
|
16.56%
|
14.77%
|
14.75%
|
16.89%
|
16.83%
|
15.68%
|
15.39%
|
17.34%
|
Earnings before Tax (EBT)
1 |
502
|
452
|
323
|
351
|
109
|
277
|
317
|
299
|
237
|
266
|
325
|
318.5
|
285
|
279.5
|
344.5
|
Net income
1 |
390
|
355
|
234
|
256
|
101
|
202
|
235
|
225
|
192
|
194
|
238
|
233.5
|
206.9
|
206.9
|
253.3
|
Net margin
|
14.21%
|
13.6%
|
9.54%
|
10.3%
|
4.33%
|
8.67%
|
10.05%
|
9.8%
|
8.39%
|
8.2%
|
9.93%
|
9.87%
|
8.88%
|
8.53%
|
10.22%
|
EPS
2 |
3.120
|
2.920
|
1.960
|
2.170
|
0.8700
|
1.780
|
2.050
|
1.960
|
1.700
|
1.720
|
2.083
|
2.063
|
1.834
|
1.861
|
2.285
|
Dividend per Share
2 |
0.6200
|
0.6600
|
0.6600
|
0.6600
|
0.6600
|
0.7100
|
0.7100
|
-
|
-
|
-
|
0.7322
|
0.7322
|
0.7322
|
0.7470
|
0.7744
|
Announcement Date
|
22-02-03
|
22-04-21
|
22-07-21
|
22-10-20
|
23-02-02
|
23-04-27
|
23-07-26
|
23-10-24
|
24-02-01
|
24-04-23
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
3,578
|
2,857
|
3,140
|
3,665
|
4,180
|
4,066
|
3,435
|
3,178
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.31
x
|
1.158
x
|
1.094
x
|
1.78
x
|
2.338
x
|
2.158
x
|
1.726
x
|
1.529
x
|
Free Cash Flow
1 |
843
|
1,587
|
1,830
|
1,314
|
864
|
895
|
1,091
|
1,241
|
ROE (net income / shareholders' equity)
|
16.5%
|
24.6%
|
28.4%
|
19.1%
|
14%
|
15.1%
|
14.9%
|
14.9%
|
ROA (Net income/ Total Assets)
|
7.51%
|
11.4%
|
13.2%
|
8.93%
|
6.36%
|
7.04%
|
7.31%
|
7.72%
|
Assets
1 |
11,417
|
12,590
|
15,091
|
10,593
|
13,430
|
12,701
|
13,140
|
13,574
|
Book Value Per Share
2 |
42.40
|
50.80
|
54.20
|
53.10
|
-
|
61.50
|
66.90
|
73.20
|
Cash Flow per Share
2 |
9.140
|
6.780
|
17.40
|
14.60
|
11.30
|
11.60
|
14.70
|
14.70
|
Capex
1 |
400
|
418
|
403
|
404
|
408
|
421
|
427
|
432
|
Capex / Sales
|
5.18%
|
4.43%
|
3.74%
|
4.09%
|
4.41%
|
4.45%
|
4.37%
|
4.29%
|
Announcement Date
|
20-01-30
|
21-02-04
|
22-02-03
|
23-02-02
|
24-02-01
|
-
|
-
|
-
|
Last Close Price
134.3
USD Average target price
146
USD Spread / Average Target +8.77% Consensus |
1st Jan change
|
Capi.
|
---|
| -2.63% | 14.92B | | -14.92% | 84.68B | | +13.30% | 81.12B | | +11.62% | 29.4B | | -12.71% | 16.73B | | -3.06% | 16.36B | | -31.75% | 11.77B | | -1.42% | 11.72B | | +27.44% | 11.71B | | -3.97% | 11.66B |
Other Healthcare Facilities & Services
|